查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888557

全球数位病理市场：市场规模、份额和趋势分析（按应用、产品、最终用途、治疗领域、类型和地区划分），细分市场预测（2025-2033 年）

Digital Pathology Market Size, Share & Trends Analysis Report By Application, By Product, By End Use, By Therapeutic Area, By Type, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 185 Pages | 商品交期: 2-10个工作天内

价格

数位病理市场摘要

预计到 2024 年，全球数位病理诊断市场规模将达到 13.9 亿美元，到 2033 年将达到 29.7 亿美元。

预计从 2025 年到 2033 年，该行业将以 8.6% 的复合年增长率增长，其增长动力来自癌症发病率的上升、对工作流程效率重要性的日益重视以及对更快诊断工具的需求不断增长。

此外，市场成长的驱动力包括：市场主要企业专注于推出新产品、远距病理诊断的日益普及以及医疗保健领域投资的增加，而这些都得益于人们对药物发现和精准医疗日益增长的兴趣。

该行业的主要驱动力是癌症等慢性疾病的日益增多。癌症的高发生率使得病理学家需要取得病理数据，以便为每位患者制定个人化治疗方法。这导致病理学家越来越倾向于使用数位病理学，因为数位病理学可以提高诊断速度、提升诊断准确性，并提供治疗建议，从而改善患者的治疗效果。例如，2024 年发表在《乳癌研究》（Breast Cancer Research）上的一项研究重点介绍了 ResNet50、Transformer 和 HoverNet 等深度学习模型在提高乳癌诊断中影像增强、分割和分类准确性方面的应用。此类案例研究显示了该市场的巨大成长潜力。

医疗保健IT解决方案的日益普及推动了对数位病理解决方案的需求。各机构正在加速采用这些解决方案，以降低成本、简化流程、应对资源短缺并促进高效的资讯共用。跨学科协作需求的日益增长以及数位化文件的扩展也是推动需求成长的因素。预计其他促进市场成长的因素包括：数位病理解决方案在提高检查室效率方面的应用日益广泛、远距医疗的蓬勃发展以及伴随诊断和药物研发领域应用的不断增长。

此外，人工智慧技术正被用于提高数位影像分析的准确性。传统上，病理学家需要手动识别组织样本中的目标区域，但人工智慧现在正在实现这一过程的自动化。这项变革减少了对人工的依赖，最大限度地降低了人为错误的风险，并促进了病理诊断任务的自动化。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 市场因素、趋势与范围

  • 市场关联性展望
    • 母市场展望
    • 相关/附随市场展望
  • 数位病理市场：市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会
    • 市场挑战
  • 商业环境分析
    • 产业分析：波特五力分析
    • PESTEL 分析
  • 科技趋势分析
  • 法律规范
  • 成本结构分析
  • 使用者观点分析
  • 案例研究

第四章 数位病理诊断市场：按产品分類的估算与趋势分析

  • 数位病理诊断市场：关键点（依产品分类）
  • 数位病理市场：按产品分類的市场趋势和份额分析（2024 年和 2033 年）
  • 软体
  • 装置
    • 扫描器
    • 幻灯片管理系统
  • 记录系统

第五章：数位病理诊断市场：按类型分類的估计和趋势分析

  • 数位病理市场：关键点（按类型划分）
  • 数位病理市场：按类型分類的市场趋势和份额分析（2024 年和 2033 年）
  • 动物病理学
  • 人体病理诊断

第六章：数位病理市场：按应用分類的估算与趋势分析

  • 数位病理市场：要点和应用
  • 数位病理市场：按应用分類的市场趋势和份额分析（2024 年和 2033 年）
  • 药物发现与开发
  • 学术研究
  • 疾病诊断
    • 癌细胞检测
    • 其他的

第七章 数位病理诊断市场：依治疗领域分類的估计与趋势分析

  • 数位病理市场：关键要点（按治疗领域划分）
  • 数位病理市场：按治疗领域分類的市场趋势和份额分析（2024 年和 2033 年）
  • 瘤
  • 循环系统
  • 神经病学
  • 其他（包括皮肤科、感染疾病、消化器官系统）

第八章：数位病理市场：依最终用途分類的估算与趋势分析

  • 数位病理市场：关键点和最终用途分析
  • 数位病理市场：按最终用途分類的市场趋势和份额分析（2024 年和 2033 年）
  • 医院
  • 生物技术和製药公司
  • 诊断检查室
  • 学术和研究机构

第九章：数位病理诊断市场：区域估计和趋势分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 荷兰
    • 瑞士
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 印度
    • 中国
    • 澳洲
    • 泰国
    • 韩国
    • 菲律宾
    • 马来西亚
    • 新加坡
    • 印尼
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 土耳其
    • 伊朗
    • 以色列
    • 科威特

第十章 竞争格局

  • 公司分类
  • 竞争对手参与策略
  • 私人公司/供应商清单：按国家/地区划分
  • 公司市占率分析（2024 年）
  • 策略规划
  • 公司简介/列表
    • Leica Biosystems Nussloch GmbH（Danaher）
    • Hamamatsu Photonics, Inc.
    • Koninklijke Philips NV
    • Olympus Corporation
    • F. Hoffmann-La Roche Ltd.
    • Mikroscan Technologies, Inc.
    • Inspirata, Inc.
    • Epredia（3DHISTECH Ltd.）
    • Visiopharm A/S
    • Huron Technologies International Inc.
    • ContextVision AB
    • CellaVision
    • HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD.（MORPHOGO）
    • West Medica Produktions-und Handels-GmbH（West Medica）
    • aetherAI
    • IBEX（IBEX Medical Analytics）
    • SigTuple Technologies Private Limited
    • Morphle Labs, Inc.
    • Bionovation Biotech, Inc.
    • Scopio Labs
    • Path Hub
    • Sectra AB
    • Agfa-Gevaert Group
    • Aiosyn
    • Proscia Inc
    • EVIDENT
    • Aignostics, Inc.
    • Aiforia
    • Dedalus SpA
    • Qritive
    • Mindpeak GmbH
    • CGI Inc.
    • Gestalt
    • OptraScan
    • Agilent Technologies, Inc.
    • KFBIO
Product Code: 978-1-68038-386-7

Digital Pathology Market Summary

The global digital pathology market size was valued at USD 1.39 billion in 2024 and is expected to reach USD 2.97 billion by 2033, growing at a CAGR of 8.6% from 2025 to 2033. This is attributed to the rising prevalence of cancer, increasing focus on improving the efficiency of workflow, and growing demand for faster diagnostic tools.

Moreover, rising investments in healthcare, aided by major key players operating in the market focusing on new launches, increasing adoption of telepathology, and an increasing focus on drug discovery and precision medicine, are propelling the market growth.

The industry is predominantly driven by the growing prevalence of chronic diseases such as cancer. As a consequence of the high prevalence of cancer, pathologists require pathology data that can facilitate customizing of therapies for patients. Thereby, digital pathology is increasingly being preferred by pathologists, as it accelerates the rate of diagnosis, increases diagnostic accuracy, and provides therapeutic recommendations to improve patient outcomes. For instance, a 2024 study published in Breast Cancer Research highlights the application of deep learning models such as ResNet50, Transformer, and Hover-net in enhancing image enhancement, segmentation, and classification for breast cancer diagnosis. Such instances signify the growth potential of the market.

Rising adoption of healthcare IT solutions is fueling the demand for digital pathology solutions. Organizations are increasingly implementing them to cut costs, streamline processes, overcome resource bottlenecks, and facilitate efficient content sharing. A growing necessity for collaborations and the expanding use of digital documentation across various scientific disciplines also drives the demand. In addition, factors such as heightened adoption to enhance laboratory efficiency, a surge in teleconsultations, and increased applications in companion diagnostics and drug discovery are expected to contribute to the market's growth.

In addition, AI is being leveraged to improve the analysis of digital images. Previously, pathologists had to manually identify regions of interest within tissue samples, but AI is now automating this process. This shift reduces the reliance on manual labor, minimizing the risk of human error and promoting greater automation in pathology practices.

Global Digital Pathology Market Report Segmentation

This report forecasts revenue growth at the global, regional and country levels and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global digital pathology market report based on product, type, application, therapeutic area, end use, and region:

  • Product Outlook (Revenue, USD Billion, 2021 - 2033)
  • Software
  • Device
    • Scanners
    • Slide Management Systems
  • Storage System
  • Type Outlook (Revenue, USD Billion, 2021 - 2033)
  • Human Pathology
  • Veterinary Pathology
  • Application Outlook (Revenue, USD Billion, 2021 - 2033)
  • Drug Discovery & Development
  • Academic Research
  • Disease Diagnosis
    • Cancer Cell Detection
    • Others
  • Therapeutic Area Outlook (Revenue, USD Billion, 2021 - 2033)
  • Oncology
  • Cardiovascular
  • Neurology
  • Others (Including dermatology, infectious diseases, gastrointestinal, etc.)
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals
  • Biotech & Pharma Companies
  • Diagnostic Labs
  • Academic & Research Institutes
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Russia
    • Spain
    • Netherlands
    • Switzerland
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Indonesia
    • Philipines
    • Australia
    • South Korea
    • Malaysia
    • Singapore
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Turkey
    • Iran
    • United Arab Emirates
    • Israel
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database:
    • 1.3.2. Gvr's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research:
    • 1.3.5. Details Of Primary Research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for Primary Interviews in Europe
      • 1.3.5.3. Data for Primary Interviews in APAC
      • 1.3.5.4. Data for Primary Interviews in Latin America
      • 1.3.5.5. Data for Primary Interviews in MEA
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Flow Analysis
    • 1.6.2. Top down market estimation
    • 1.6.3. CAGR Calculation
    • 1.6.4. Key Report Updates
  • 1.7. List of Secondary Sources
  • 1.8. List of Abbreviations
  • 1.9. Report Objectives
    • 1.9.1. Objective - 1
    • 1.9.2. Objective - 2

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segmental Snapshot
  • 2.3. Competitive Insights Snapshot

Chapter 3. Market Variables, Trends, and Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Analysis
    • 3.1.2. Ancillary Market Analysis
  • 3.2. Digital Pathology Market- Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing integration of AI in digital patholgy
      • 3.2.1.2. Growing adoption of digital pathology solutions in veterinary care practices
      • 3.2.1.3. Increasing demand for integrated healthcare systems and patient-centric care
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of implementing digital pathology solutions
      • 3.2.2.2. Lack of Skilled Professionals
    • 3.2.3. Industry Challenges
    • 3.2.4. Industry Oppurtinity
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape
  • 3.4. Technology Trend Analysis
  • 3.5. Regulatory Framework
  • 3.6. Cost Structure Analysis
  • 3.7. User Perspective Analysis
  • 3.8. Case Studies

Chapter 4. Digital Pathology Market: Product Estimates & Trend Analysis

  • 4.1. Digital Pathology Market, Product: Key Takeaways
  • 4.2. Digital Pathology Market: Product Movement & Market Share Analysis, 2024 & 2033
  • 4.3. Software
    • 4.3.1. Software Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
      • 4.3.1.1. Software market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.4. Devices
    • 4.4.1. Devices Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2. Scanners
      • 4.4.2.1. scanners market estimates and forecast, 2021 - 2033 (USD Million)
    • 4.4.3. Slide Management System
      • 4.4.3.1. slide management system market estimates and forecast, 2021 - 2033 (USD Million)
  • 4.5. Storage Systems
    • 4.5.1. Storage Systems Market Estimates And Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Digital Pathology Market: Type Estimates & Trend Analysis

  • 5.1. Digital Pathology Market, by Type: Key Takeaways
  • 5.2. Digital Pathology Market: Type Movement & Market Share Analysis, 2024 & 2033
  • 5.3. Veterinary Pathology
    • 5.3.1. Veterinary Pathology Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • 5.4. Human Pathology
    • 5.4.1. Human Pathology Market Estimates And Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Digital Pathology Market: Application Estimates & Trend Analysis

  • 6.1. Digital Pathology Market, Application Type: Key Takeaways
  • 6.2. Digital Pathology Market: Application Movement & Market Share Analysis, 2024 & 2033
  • 6.3. Drug Discovery & Development
    • 6.3.1. Drug Discovery & Development Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • 6.4. Academic Research
    • 6.4.1. Academic Research Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • 6.5. Disease Diagnosis
    • 6.5.1. Disease Diagnosis Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
    • 6.5.2. Cancer Cell Detection
      • 6.5.2.1. Cancer Cell Detection Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
    • 6.5.3. Others
      • 6.5.3.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Digital Pathology Market: Therapeutic Area Estimates & Trend Analysis

  • 7.1. Digital Pathology Market, Therapeutic Area: Key Takeaways
  • 7.2. Digital Pathology Market: Therapeutic Area Movement & Market Share Analysis, 2024 & 2033
  • 7.3. Oncology
    • 7.3.1. Oncology Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • 7.4. Cardiovascular
    • 7.4.1. Cardiovascular Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • 7.5. Neurology
    • 7.5.1. Neurology Market Estimates And Forecasts, 2021 - 2033 (USD Billion)
  • 7.6. Others (Including dermatology, infectious diseases, gastrointestinal, etc.)
    • 7.6.1. Others Market Estimates And Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Digital Pathology Market: End Use Estimates & Trend Analysis

  • 8.1. Digital Pathology Market, By End Use: Key Takeaways
  • 8.2. Digital Pathology Market: End Use Movement & Market Share Analysis, 2024 & 2033
  • 8.3. Hospitals
    • 8.3.1. Hospitals Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.4. Biotech & Pharma Companies
    • 8.4.1. Biotech & Pharma Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.5. Diagnostics Labs
    • 8.5.1. Diagnostics Labs Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Academic & Research Institutes
    • 8.6.1. Academic & Research Institutes Market Estimates And Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Digital Pathology Market: Regional Estimates & Trend Analysis

  • 9.1 North America
    • 9.1.1 North America Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.1.2 U.S.
      • 9.1.2.1 Key Country Dynamics
      • 9.1.2.2 Competitive Scenario
      • 9.1.2.3 Regulatory Framework
      • 9.1.2.4 Reimbursement Scenario
      • 9.1.2.5 U.S. Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.1.3 Canada
      • 9.1.3.1 Key Country Dynamics
      • 9.1.3.2 Competitive Scenario
      • 9.1.3.3 Regulatory Framework
      • 9.1.3.4 Reimbursement Scenario
      • 9.1.3.5 Canada Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.1.4 Mexico
      • 9.1.4.1 Key Country Dynamics
      • 9.1.4.2 Competitive Scenario
      • 9.1.4.3 Regulatory Framework
      • 9.1.4.4 Reimbursement Scenario
      • 9.1.4.5 Mexico Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 9.2 Europe
    • 9.2.1 Europe Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.2 UK
      • 9.2.2.1 Key Country Dynamics
      • 9.2.2.2 Competitive Scenario
      • 9.2.2.3 Regulatory Framework
      • 9.2.2.4 Reimbursement Scenario
      • 9.2.2.5 UK Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.3 Germany
      • 9.2.3.1 Key Country Dynamics
      • 9.2.3.2 Competitive Scenario
      • 9.2.3.3 Regulatory Framework
      • 9.2.3.4 Reimbursement Scenario
      • 9.2.3.5 Germany Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.4 France
      • 9.2.4.1 Key Country Dynamics
      • 9.2.4.2 Competitive Scenario
      • 9.2.4.3 Regulatory Framework
      • 9.2.4.4 Reimbursement Scenario
      • 9.2.4.5 France Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.5 Italy
      • 9.2.5.1 Key Country Dynamics
      • 9.2.5.2 Competitive Scenario
      • 9.2.5.3 Regulatory Framework
      • 9.2.5.4 Reimbursement Scenario
      • 9.2.5.5 Italy Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.6 Spain
      • 9.2.6.1 Key Country Dynamics
      • 9.2.6.2 Competitive Scenario
      • 9.2.6.3 Regulatory Framework
      • 9.2.6.4 Reimbursement Scenario
      • 9.2.6.5 Spain Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.7 Russia
      • 9.2.7.1 Key Country Dynamics
      • 9.2.7.2 Competitive Scenario
      • 9.2.7.3 Regulatory Framework
      • 9.2.7.4 Reimbursement Scenario
      • 9.2.7.5 Russia Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.8 Netherland
      • 9.2.8.1 Key Country Dynamics
      • 9.2.8.2 Competitive Scenario
      • 9.2.8.3 Regulatory Framework
      • 9.2.8.4 Reimbursement Scenario
      • 9.2.8.5 Netherland Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.9 Switzerland
      • 9.2.9.1 Key Country Dynamics
      • 9.2.9.2 Competitive Scenario
      • 9.2.9.3 Regulatory Framework
      • 9.2.9.4 Reimbursement Scenario
      • 9.2.9.5 Switzerland Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.10 Denmark
      • 9.2.10.1 Key Country Dynamics
      • 9.2.10.2 Competitive Scenario
      • 9.2.10.3 Regulatory Framework
      • 9.2.10.4 Reimbursement Scenario
      • 9.2.10.5 Denmark Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.11 Sweden
      • 9.2.11.1 Key Country Dynamics
      • 9.2.11.2 Competitive Scenario
      • 9.2.11.3 Regulatory Framework
      • 9.2.11.4 Reimbursement Scenario
      • 9.2.11.5 Sweden Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.2.12 Norway
      • 9.2.12.1 Key Country Dynamics
      • 9.2.12.2 Competitive Scenario
      • 9.2.12.3 Regulatory Framework
      • 9.2.12.4 Reimbursement Scenario
      • 9.2.12.5 Norway Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.2 Japan
      • 9.3.2.1 Key Country Dynamics
      • 9.3.2.2 Competitive Scenario
      • 9.3.2.3 Regulatory Framework
      • 9.3.2.4 Reimbursement Scenario
      • 9.3.2.5 Japan Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.3 India
      • 9.3.3.1 Key Country Dynamics
      • 9.3.3.2 Competitive Scenario
      • 9.3.3.3 Regulatory Framework
      • 9.3.3.4 Reimbursement Scenario
      • 9.3.3.5 India Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.4 China
      • 9.3.4.1 Key Country Dynamics
      • 9.3.4.2 Competitive Scenario
      • 9.3.4.3 Regulatory Framework
      • 9.3.4.4 Reimbursement Scenario
      • 9.3.4.5 China Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.5 Australia
      • 9.3.5.1 Key Country Dynamics
      • 9.3.5.2 8. 6. 3.5competitive Scenario
      • 9.3.5.3 Regulatory Framework
      • 9.3.5.4 Reimbursement Scenario
      • 9.3.5.5 Australia Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.6 Thailand
      • 9.3.6.1 Key Country Dynamics
      • 9.3.6.2 8. Competitive Scenario
      • 9.3.6.3 Regulatory Framework
      • 9.3.6.4 Reimbursement Scenario
      • 9.3.6.5 Thailand Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.7 South Korea
      • 9.3.7.1 Key Country Dynamics
      • 9.3.7.2 Competitive Scenario
      • 9.3.7.3 Regulatory Framework
      • 9.3.7.4 Reimbursement Scenario
      • 9.3.7.5 South Korea Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.8 Philiipines
      • 9.3.8.1 Key Country Dynamics
      • 9.3.8.2 Competitive Scenario
      • 9.3.8.3 Regulatory Framework
      • 9.3.8.4 Reimbursement Scenario
      • 9.3.8.5 Philipines Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.9 Malaysia
      • 9.3.9.1 Key Country Dynamics
      • 9.3.9.2 Competitive Scenario
      • 9.3.9.3 Regulatory Framework
      • 9.3.9.4 Reimbursement Scenario
      • 9.3.9.5 Malaysia Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.10 Singapore
      • 9.3.10.1 Key Country Dynamics
      • 9.3.10.2 Competitive Scenario
      • 9.3.10.3 Regulatory Framework
      • 9.3.10.4 Reimbursement Scenario
      • 9.3.10.5 Singapore Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.3.11 Indonesia
      • 9.3.11.1 Key Country Dynamics
      • 9.3.11.2 Competitive Scenario
      • 9.3.11.3 Regulatory Framework
      • 9.3.11.4 Reimbursement Scenario
      • 9.3.11.5 Singapore Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 9.4 Latin America
    • 9.4.1 Latin America Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.4.2 Brazil
      • 9.4.2.1 Key Country Dynamics
      • 9.4.2.2 Competitive Scenario
      • 9.4.2.3 Regulatory Framework
      • 9.4.2.4 Reimbursement Scenario
      • 9.4.2.5 Brazil Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.4.3 Argentina
      • 9.4.3.1 Key Country Dynamics
      • 9.4.3.2 Competitive Scenario
      • 9.4.3.3 Regulatory Framework
      • 9.4.3.4 Reimbursement Scenario
      • 9.4.3.5 Argentina Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
  • 9.5 MEA
    • 9.5.1 MEA Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.5.2 South Africa
      • 9.5.2.1 Key Country Dynamics
      • 9.5.2.2 Competitive Scenario
      • 9.5.2.3 Regulatory Framework
      • 9.5.2.4 Reimbursement Scenario
      • 9.5.2.5 South Africa Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.5.3 Saudi Arabia
      • 9.5.3.1 Key Country Dynamics
      • 9.5.3.2 Competitive Scenario
      • 9.5.3.3 Regulatory Framework
      • 9.5.3.4 Reimbursement Scenario
      • 9.5.3.5 Saudi Arabia Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.5.4 UAE
      • 9.5.4.1 Key Country Dynamics
      • 9.5.4.2 Competitive Scenario
      • 9.5.4.3 Regulatory Framework
      • 9.5.4.4 Reimbursement Scenario
      • 9.5.4.5 UAE Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.5.5 Turkey
      • 9.5.5.1 Key Country Dynamics
      • 9.5.5.2 Competitive Scenario
      • 9.5.5.3 Regulatory Framework
      • 9.5.5.4 Reimbursement Scenario
      • 9.5.5.5 Turkey Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.5.6 Iran
      • 9.5.6.1 Key Country Dynamics
      • 9.5.6.2 Competitive Scenario
      • 9.5.6.3 Regulatory Framework
      • 9.5.6.4 Reimbursement Scenario
      • 9.5.6.5 Iran Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.5.7 Isarel
      • 9.5.7.1 Key Country Dynamics
      • 9.5.7.2 Competitive Scenario
      • 9.5.7.3 Regulatory Framework
      • 9.5.7.4 Reimbursement Scenario
      • 9.5.7.5 Israel Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)
    • 9.5.8 Kuwait
      • 9.5.8.1 Key Country Dynamics
      • 9.5.8.2 Competitive Scenario
      • 9.5.8.3 Regulatory Framework
      • 9.5.8.4 Reimbursement Scenario
      • 9.5.8.5 Kuwait Digital Pathology Market Estimates And Forecast, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Competitive Market Entry Strategies
  • 10.3. Private Companies/ Vendors, By Country/Region
  • 10.4. Company Market Share Analysis, 2024
  • 10.5. Strategy Mapping
  • 10.6. Company Profiles/Listing
    • 10.6.1. Leica Biosystems Nussloch GmbH (Danaher)
      • 10.6.1.1. Overview
      • 10.6.1.2. Financial Performance
      • 10.6.1.3. Product Benchmarking
      • 10.6.1.4. Strategic Initiatives
    • 10.6.2. Hamamatsu Photonics, Inc.
      • 10.6.2.1. Overview
      • 10.6.2.2. Financial Performance
      • 10.6.2.3. Product Benchmarking
      • 10.6.2.4. Strategic Initiatives
    • 10.6.3. Koninklijke Philips N.V.
      • 10.6.3.1. Overview
      • 10.6.3.2. Financial Performance
      • 10.6.3.3. Product Benchmarking
      • 10.6.3.4. Strategic Initiatives
    • 10.6.4. Olympus Corporation
      • 10.6.4.1. Overview
      • 10.6.4.2. Financial Performance
      • 10.6.4.3. Product Benchmarking
      • 10.6.4.4. Strategic Initiatives
    • 10.6.5. F. Hoffmann-La Roche Ltd.
      • 10.6.5.1. Overview
      • 10.6.5.2. Financial Performance
      • 10.6.5.3. Product Benchmarking
      • 10.6.5.4. Strategic Initiatives
    • 10.6.6. Mikroscan Technologies, Inc.
      • 10.6.6.1. Overview
      • 10.6.6.2. Financial Performance
      • 10.6.6.3. Product Benchmarking
      • 10.6.6.4. Strategic Initiatives
    • 10.6.7. Inspirata, Inc.
      • 10.6.7.1. Overview
      • 10.6.7.2. Financial Performance
      • 10.6.7.3. Product Benchmarking
      • 10.6.7.4. Strategic Initiatives
    • 10.6.8. Epredia (3DHISTECH Ltd.)
      • 10.6.8.1. Overview
      • 10.6.8.2. Financial Performance
      • 10.6.8.3. Product Benchmarking
      • 10.6.8.4. Strategic Initiatives
    • 10.6.9. Visiopharm A/S
      • 10.6.9.1. Overview
      • 10.6.9.2. Financial Performance
      • 10.6.9.3. Product Benchmarking
      • 10.6.9.4. Strategic Initiatives
    • 10.6.10. Huron Technologies International Inc.
      • 10.6.10.1. Overview
      • 10.6.10.2. Financial Performance
      • 10.6.10.3. Product Benchmarking
      • 10.6.10.4. Strategic Initiatives
    • 10.6.11. ContextVision AB
      • 10.6.11.1. Overview
      • 10.6.11.2. Financial Performance
      • 10.6.11.3. Product Benchmarking
      • 10.6.11.4. Strategic Initiatives
    • 10.6.12. CellaVision
      • 10.6.12.1. Overview
      • 10.6.12.2. Financial Performance
      • 10.6.12.3. Product Benchmarking
      • 10.6.12.4. Strategic Initiatives
    • 10.6.13. HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
      • 10.6.13.1. Overview
      • 10.6.13.2. Financial Performance
      • 10.6.13.3. Product Benchmarking
      • 10.6.13.4. Strategic Initiatives
    • 10.6.14. West Medica Produktions- und Handels- GmbH (West Medica)
      • 10.6.14.1. Overview
      • 10.6.14.2. Financial Performance
      • 10.6.14.3. Product Benchmarking
      • 10.6.14.4. Strategic Initiatives
    • 10.6.15. aetherAI
      • 10.6.15.1. Overview
      • 10.6.15.2. Financial Performance
      • 10.6.15.3. Product Benchmarking
      • 10.6.15.4. Strategic Initiatives
    • 10.6.16. IBEX (IBEX Medical Analytics)
      • 10.6.16.1. Overview
      • 10.6.16.2. Financial Performance
      • 10.6.16.3. Product Benchmarking
      • 10.6.16.4. Strategic Initiatives
    • 10.6.17. SigTuple Technologies Private Limited
      • 10.6.17.1. Overview
      • 10.6.17.2. Financial Performance
      • 10.6.17.3. Product Benchmarking
      • 10.6.17.4. Strategic Initiatives
    • 10.6.18. Morphle Labs, Inc.
      • 10.6.18.1. Overview
      • 10.6.18.2. Financial Performance
      • 10.6.18.3. Product Benchmarking
      • 10.6.18.4. Strategic Initiatives
    • 10.6.19. Bionovation Biotech, Inc.
      • 10.6.19.1. Overview
      • 10.6.19.2. Financial Performance
      • 10.6.19.3. Product Benchmarking
      • 10.6.19.4. Strategic Initiatives
    • 10.6.20. Scopio Labs
      • 10.6.20.1. Overview
      • 10.6.20.2. Financial Performance
      • 10.6.20.3. Product Benchmarking
      • 10.6.20.4. Strategic Initiatives
    • 10.6.21. Path Hub
      • 10.6.21.1. Overview
      • 10.6.21.2. Financial Performance
      • 10.6.21.3. Product Benchmarking
      • 10.6.21.4. Strategic Initiatives
    • 10.6.22. Sectra AB
      • 10.6.22.1. Overview
      • 10.6.22.2. Financial Performance
      • 10.6.22.3. Product Benchmarking
      • 10.6.22.4. Strategic Initiatives
    • 10.6.23. Agfa-Gevaert Group
      • 10.6.23.1. Overview
      • 10.6.23.2. Financial Performance
      • 10.6.23.3. Product Benchmarking
      • 10.6.23.4. Strategic Initiatives
    • 10.6.24. Aiosyn
      • 10.6.24.1. Overview
      • 10.6.24.2. Financial Performance
      • 10.6.24.3. Product Benchmarking
      • 10.6.24.4. Strategic Initiatives
    • 10.6.25. Proscia Inc
      • 10.6.25.1. Overview
      • 10.6.25.2. Financial Performance
      • 10.6.25.4. Strategic Initiatives
    • 10.6.26. EVIDENT
      • 10.6.26.1. Overview
      • 10.6.26.2. Financial Performance
      • 10.6.26.3. Product Benchmarking
      • 10.6.26.4. Strategic Initiatives
    • 10.6.27. Aignostics, Inc.
      • 10.6.27.1. Overview
      • 10.6.27.2. Financial Performance
      • 10.6.27.3. Product Benchmarking
      • 10.6.27.4. Strategic Initiatives
    • 10.6.33. Aiforia
      • 10.6.33.1. Overview
      • 10.6.33.2. Financial Performance
      • 10.6.33.3. Product Benchmarking
      • 10.6.33.4. Strategic Initiatives
    • 10.6.34. Dedalus S.p.A
      • 10.6.34.1. Overview
      • 10.6.34.2. Financial Performance
      • 10.6.34.3. Product Benchmarking
      • 10.6.34.4. Strategic Initiatives
    • 10.6.35. Qritive
      • 10.6.35.1. Overview
      • 10.6.35.2. Financial Performance
      • 10.6.35.3. Product Benchmarking
      • 10.6.35.4. Strategic Initiatives
    • 10.6.36. Mindpeak GmbH
      • 10.6.36.1. Overview
      • 10.6.36.2. Financial Performance
      • 10.6.36.3. Product Benchmarking
      • 10.6.36.4. Strategic Initiatives
    • 10.6.37. CGI Inc.
      • 10.6.37.1. Overview
      • 10.6.37.2. Financial Performance
      • 10.6.37.3. Product Benchmarking
      • 10.6.37.4. Strategic Initiatives
    • 10.6.38. Gestalt
      • 10.6.38.1. Overview
      • 10.6.38.2. Financial Performance
      • 10.6.38.3. Product Benchmarking
      • 10.6.38.4. Strategic Initiatives
    • 10.6.39. OptraScan
      • 10.6.39.1. Overview
      • 10.6.39.2. Financial Performance
      • 10.6.39.3. Product Benchmarking
      • 10.6.39.4. Strategic Initiatives
    • 10.6.40. Agilent Technologies, Inc.
      • 10.6.40.1. Overview
      • 10.6.40.2. Financial Performance
      • 10.6.40.3. Product Benchmarking
      • 10.6.40.4. Strategic Initiatives
    • 10.6.41. KFBIO
      • 10.6.41.1. Overview
      • 10.6.41.2. Financial Performance
      • 10.6.41.3. Product Benchmarking
      • 10.6.41.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 List of secondary data sources
  • Table 3 Global Digital Pathology Market, By Region, 2021 - 2033 (USD Million)
  • Table 4 Global Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 Global Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 6 Global Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 7 Global Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 8 Global Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 9 North America Digital Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 10 North America Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 11 North America Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 12 North America Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 13 North America Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 14 North America Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 15 U.S. Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 16 U.S. Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 17 U.S. Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 18 U.S. Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 19 U.S. Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 20 Canada Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 21 Canada Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 22 Canada Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 23 Canada Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 24 Canada Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Digital Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 28 Europe Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Europe Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 30 Europe Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 31 UK Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 32 UK Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 33 UK Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 34 UK Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 35 UK Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 36 Germany Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 Germany Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 38 Germany Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 39 Germany Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40 Germany Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 41 France Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 42 France Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 43 France Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 44 France Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 45 France Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 46 Italy Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Italy Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 48 Italy Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Italy Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50 Italy Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 51 Spain Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 52 Spain Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 53 Spain Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 54 Spain Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 55 Spain Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 56 Denmark Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 57 Denmark Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 58 Denmark Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 59 Denmark Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 60 Denmark Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 61 Norway Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 62 Norway Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 63 Norway Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 64 Norway Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65 Norway Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 66 Sweden Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 67 Sweden Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 68 Sweden Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 69 Sweden Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 70 Sweden Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 71 Russia Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 Russia Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 73 Russia Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 Russia Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75 Russia Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 76 Netherland Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 77 Netherland Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 78 Netherland Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 79 Netherland Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 80 Netherland Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 81 Switzerland Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 82 Switzerland Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 83 Switzerland Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 84 Switzerland Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 85 Switzerland Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 86 Asia Pacific Digital Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 87 Asia Pacific Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 Asia Pacific Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 89 Asia Pacific Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 Asia Pacific Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91 Asia Pacific Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 92 Japan Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Japan Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 94 Japan Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Japan Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 96 Japan Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 97 China Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 98 China Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 99 China Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 100 China Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 101 China Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 102 India Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 103 India Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 104 India Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 105 India Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 106 India Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 107 South Korea Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 108 South Korea Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 109 South Korea Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 110 South Korea Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 111 South Korea Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 112 Australia Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 113 Australia Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 114 Australia Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 115 Australia Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 116 Australia Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 117 Philippines Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 Philippines Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 119 Philippines Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 120 Philippines Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 121 Philippines Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 122 Indonesia Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 123 Indonesia Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 124 Indonesia Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 125 Indonesia Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 126 Indonesia Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 127 Malaysia Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 128 Malaysia Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 129 Malaysia Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 130 Malaysia Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 131 Malaysia Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 132 Singapore Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 133 Singapore Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 134 Singapore Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 135 Singapore Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 136 Singapore Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 137 Latin America Digital Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 138 Latin America Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 139 Latin America Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 140 Latin America Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 141 Latin America Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 142 Latin America Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 143 Brazil Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 144 Brazil Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 145 Brazil Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 146 Brazil Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 147 Brazil Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 148 Argentina Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 149 Argentina Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 150 Argentina Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 151 Argentina Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 152 Argentina Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 153 Middle East and Africa Digital Pathology Market, By Country, 2021 - 2033 (USD Million)
  • Table 154 Middle East and Africa Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 155 Middle East and Africa Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 156 Middle East and Africa Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 157 Middle East Africa Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 158 Middle East and Africa Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 159 South Africa Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 160 South Africa Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 161 South Africa Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 162 South Africa Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 163 South Africa Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 164 Saudi Arabia Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 165 Saudi Arabia Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 166 Saudi Arabia Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 167 Saudi Arabia Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 168 Saudi Arabia Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 169 UAE Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 170 UAE Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 171 UAE Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 172 UAE Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 173 UAE Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 174 Turkey Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 175 Turkey Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 176 Turkey Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 177 Turkey Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 178 Turkey Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 179 Iran Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 180 Iran Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 181 Iran Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 182 Iran Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 183 Iran Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 184 Israel Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 185 Israel Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 186 Israel Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 187 Israel Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 188 Israel Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)
  • Table 189 Kuwait Digital Pathology Market, By Product, 2021 - 2033 (USD Million)
  • Table 190 Kuwait Digital Pathology Market, By Type, 2021 - 2033 (USD Million)
  • Table 191 Kuwait Digital Pathology Market, By Application, 2021 - 2033 (USD Million)
  • Table 192 Kuwait Digital Pathology Market, By Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 193 Kuwait Digital Pathology Market, By End-Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Digital pathology market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Digital pathology market: Product movement analysis
  • Fig. 17 Digital pathology market: Product segment dashboard
  • Fig. 18 Digital pathology market product outlook: Key takeaways
  • Fig. 19 Software market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Device market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Scanners market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Slide Management Systems market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Storage system market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Digital pathology market: Type movement analysis
  • Fig. 25 Digital pathology market: Type segment dashboard
  • Fig. 26 Digital pathology market Type outlook: Key takeaways
  • Fig. 27 Human digital pathology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Veterinary digital pathology market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Digital pathology market: Application movement analysis
  • Fig. 30 Digital pathology market: Application segment dashboard
  • Fig. 31 Digital pathology market application outlook: Key takeaways
  • Fig. 32 Drug discovery & development market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Academic research market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Disease diagnosis market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 35 Digital pathology market: Therapeutic Area movement analysis
  • Fig. 36 Digital pathology market: Therapeutic Area segment dashboard
  • Fig. 37 Oncology market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 38 Cardiovascular market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 39 Neurology market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 40 Others market estimates and forecast, 2021 - 2033 (USD Billion)
  • Fig. 41 Digital pathology market: End-use movement analysis
  • Fig. 42 Digital pathology market: End-use segment dashboard
  • Fig. 43 Digital pathology market end-use outlook: Key takeaways
  • Fig. 44 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Biotech & pharma companies market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Diagnostic labs market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Academic &research institutes market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Regional outlook, 2024 & 2033
  • Fig. 49 Regional market dashboard
  • Fig. 50 Regional market place: Key takeaways
  • Fig. 51 North America, SWOT
  • Fig. 52 Europe, SWOT
  • Fig. 53 Asia Pacific, SWOT
  • Fig. 54 Latin America, SWOT
  • Fig. 55 Middle East and Africa, SWOT
  • Fig. 56 North America
  • Fig. 57 North America Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 58 U.S. Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 59 Canada Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 60 Mexico Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 61 Europe Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 62 UK Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 63 Germany Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 64 Spain Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 65 France Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 66 Italy Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 67 Russia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 68 Netherlands Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 69 Switzerland Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 70 Denmark Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 71 Norway Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 72 Sweden Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 73 Asia Pacific Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 74 Japan Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 75 China Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 76 India Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 77 South Korea Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 78 Australia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 79 Philippines Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 80 Indonesia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 81 South Korea Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 82 Philippines Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 83 Malaysia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 84 Singapore Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 85 Latin America Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 86 Brazil Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 87 Argentina Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 88 MEA Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 89 South Africa Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 90 Saudi Arabia Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 91 Turkey Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 92 Iran Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 93 UAE Digital Pathology market, 2021 - 2033 (USD Million)
  • Fig. 94 Israel Digital pathology market, 2021 - 2033 (USD Million)
  • Fig. 95 Kuwait Digital pathology market, 2021 - 2033 (USD Million)